Personal information

No personal information available

Activities

Collapse all

Works (10)

Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed

British Journal of Dermatology
2021-03 | Journal article | Author
DOI: 10.1111/bjd.19434
Part of ISSN: 0007-0963
Part of ISSN: 1365-2133
Contributors: Paula Dávila-Seijo
Source: Self-asserted source
Paula Dávila-Seijo

How real are ‘real‐life studies’ in psoriasis, and the uncertain meaning of drug persistence

British Journal of Dermatology
2019-01 | Journal article
DOI: 10.1111/bjd.17104
Part of ISSN: 0007-0963
Part of ISSN: 1365-2133
Contributors: Ignacio Garcia-Doval; P. Dávila‐Seijo
Source: Self-asserted source
Paula Dávila-Seijo

Clinical Research in Dermatology in Spain

Actas Dermo-Sifiliográficas (English Edition)
2017-11 | Journal article
DOI: 10.1016/j.adengl.2017.06.021
Part of ISSN: 1578-2190
Contributors: P. Dávila Seijo
Source: Self-asserted source
Paula Dávila-Seijo

Registries as real-world cohort studies that are useful and necessary in the pyramid of evidence.

The British journal of dermatology
2017-11-29 | Journal article | Author
DOI: 10.1111/bjd.15968
PMID: 28889457
Contributors: Paula Dávila-Seijo; Descalzo MA
Source: Self-asserted source
Paula Dávila-Seijo

Response to the Comment by Van den Reek et al. on Drug Survival Analysis is not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis.

Actas dermo-sifiliograficas
2017-05-12 | Journal article
DOI: 10.1016/j.ad.2017.03.011
PMID: 28504087
Contributors: Dávila-Seijo P; Ignacio Garcia-Doval
Source: Self-asserted source
Paula Dávila-Seijo

Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries.

Acta dermato-venereologica
2017-04-01 | Journal article
DOI: 10.2340/00015555-2586
PMID: 27882386
Contributors: Davila-Seijo P; Ignacio Garcia-Doval; Naldi L; Simone Cazzaniga; Augustin M; Rustenbach SJ; Daudén E; Dam TN; Baker C; Phyllis Spuls et al.
Source: Self-asserted source
Paula Dávila-Seijo

Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis.

Actas dermo-sifiliograficas
2016-10-17 | Journal article
DOI: 10.1016/j.ad.2016.09.001
PMID: 27765164
Contributors: Dávila-Seijo P; Ignacio Garcia-Doval
Source: Self-asserted source
Paula Dávila-Seijo

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.

The Journal of investigative dermatology
2016-09-25 | Journal article
DOI: 10.1016/j.jid.2016.08.034
PMID: 27677836
Contributors: Dávila-Seijo P; Dauden E; Descalzo MA; Carretero G; Carrascosa JM; Vanaclocha F; Francisco Jose Gomez Garcia; De la Cueva-Dobao P; Herrera-Ceballos E; Isabel Belinchón et al.
Source: Self-asserted source
Paula Dávila-Seijo

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV
2016-06-22 | Journal article
DOI: 10.1111/jdv.13682
PMID: 27329511
Contributors: Dávila-Seijo P; Dauden E; Carretero G; Ferrandiz C; Vanaclocha F; Francisco Jose Gomez Garcia; Herrera-Ceballos E; De la Cueva-Dobao P; Isabel Belinchón ; Sánchez-Carazo JL et al.
Source: Self-asserted source
Paula Dávila-Seijo

Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership.

The British journal of dermatology
2015-08-12 | Journal article
DOI: 10.1111/bjd.13914
PMID: 25996448
Contributors: Hernández-Martín A; Dávila-Seijo P; de Lucas R; Baselga E; PEDRO REDONDO; Martín-Santiago A; Azaña-Defez JM; González-Viejo I; Jiménez-Ferreres L; González-Enseñat MA et al.
Source: Self-asserted source
Paula Dávila-Seijo
How many people are using ORCID?